Biotech stocks falling today reasons?

I don’t have real-time market data, but biotech stocks tend to fall for a few recurring reasons. Here’s a quick framework to think about what might be driving a drop today:

- Macro/market factors
- Overall risk-off mood or rotation out of growth/biotech names
- Higher interest rates or a stronger dollar, which reduce the present value of future biotech cash flows
- Sector-specific sentiment shifts or broad market news

- Company-specific clinical and regulatory catalysts
- Negative trial results or safety concerns (adverse events, endpoints not met)
- Delays or halts in ongoing trials
- Regulator actions (FDA advisory committee recommendations against, complete response letters, or requests for more data)

- Pipeline and competitive dynamics
- New data from a competitor’s therapy or a major competitor’s approval affecting market size
- Emergence of a superior treatment or a faster development timeline by peers

- Financials and capital needs
- Cash burn and need for new funding leading to dilution concerns
- Poor quarterly results or guidance that misses expectations
- Financing announcements that could dilute existing shareholders

- Partnerships, licensing, and M&A
- Deals falling through or terms unfavorably revised
- Loss of a key collaboration or milestone payments

- Operational and manufacturing issues
- Manufacturing setbacks, supply chain problems, or scale-up challenges

If you want, tell me the ticker symbols or the date, and I can pull together a concise summary of the likely catalysts or headlines driving those moves (and point you to the primary sources, like press releases or regulatory filings). I can also help you assess how much of the move is driven by a single event versus broader market factors.